Pharmacokinetic interactions between ivacaftor and cytochrome P450 3A4 inhibitors in people with cystic fibrosis and healthy controls
Renske van der Meer, Erik B. Wilms, Richart Sturm, Harry Heijerman
Topics & Concepts
IvacaftorCystic fibrosisRitonavirPharmacokineticsCYP3A4MedicinePharmacologyClarithromycinAzithromycinCystic fibrosis transmembrane conductance regulatorInternal medicineGastroenterologyCytochrome P450ChemistryImmunologyAntibioticsHuman immunodeficiency virus (HIV)Viral loadHelicobacter pyloriAntiretroviral therapyMetabolismBiochemistryCystic Fibrosis Research AdvancesAsthma and respiratory diseasesDrug-Induced Adverse Reactions